Cargando…
Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway
BACKGROUND: Previous studies have reported that the combination of metformin and bevacizumab exhibit favorable efficacy in the treatment of cancer patients, and metformin possesses effects on relieving vascular injury in multiple diseases. Nonetheless, the effect of metformin in alleviating bevacizu...
Autores principales: | Chen, Liqiang, Yin, Yajuan, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576656/ https://www.ncbi.nlm.nih.gov/pubmed/34790753 http://dx.doi.org/10.21037/atm-21-4764 |
Ejemplares similares
-
PPARα Targeting GDF11 Inhibits Vascular Endothelial Cell Senescence in an Atherosclerosis Model
por: Dou, Fangfang, et al.
Publicado: (2021) -
Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation
por: Ge, Zhijuan, et al.
Publicado: (2015) -
Metformin promotes osteogenic differentiation and prevents hyperglycaemia-induced osteoporosis by suppressing PPARγ expression: Metformin prevents osteoporosis by suppressing PPARγ
por: Zheng, Lifeng, et al.
Publicado: (2023) -
Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
por: Nozhat, Zahra, et al.
Publicado: (2018) -
Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway
por: Jiao, Yi, et al.
Publicado: (2019)